Consistently, data from tissue microassays of 305 patients with lung cancer showed that TLS were more abundant in non–small cell lung cancer (NSCLC) tissues with lower ACAT1 expression. The gene discussed is ACAT1; the disease is non-small cell lung carcinoma.